pharmaphorum

APRIL 29, 2022

An artificial intelligence-powered digital tool for diagnosing skin cancers developed by Skin Analytics has been cleared in the UK as a Class IIA medical device, setting up broader use of the technology in patient assessments. DERM is being deployed in pilot studies across five NHS Trusts, for example to see if it can support GPs in referring patients to the urgent two week skin cancer referral laid out in NICE guidelines.

Hospitals 145

Hospitals 145

Outsourcing Pharma

APRIL 26, 2022

The companyâs Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.

89

89

Pharma Times

APRIL 28, 2022

Women, those who are obese and those on mechanical ventilation are all more likely to suffer from the effects long-term COVID-19

59

59

Fossil Remedies

APRIL 26, 2022

PCD Pharma Business Plan. In a pharmaceutical business, you need a link between the pharma marketing company and the end-user, i.e., doctors, pharmacists, or others who can prescribe the medicine. This connecting link is the PCD Pharma Business. The full form of PCD is Propaganda Cum Distribution. Are you a person who wants to know about the details of preparing a successful PCD pharma business plan?

Documentation 59

Documentation 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

APRIL 25, 2022

An analysis of 10 clinical trials of digital health interventions targeted at patients recently hospitalised for acute heart failure has found they improve outcomes compared to standard care. The meta-analysis by researchers in the US pooled the results of the studies to assess the impact of digital approaches like telemedicine, use of monitoring sensors, Internet-based interventions, smartphone apps, or text messaging/email interactions on all-cause mortality.

Hospitals 139

Hospitals 139

The Honest Apothecary

APRIL 29, 2022

Focus is the secret to improvement in any area of your life and career. What you focus on, you will get better at. Whether it be art, or sports, or business, or any other area of interest…focus makes the difference between progress and plateau. When an organization, or an individual, loses their focus, they will slowly but surely decline. No focus = no progress.

52

52

The Luxe Pharmacist

APRIL 27, 2022

Why did I go into pharmacy? I have a whole post post dedicated to this topic that I wrote years ago! You can read it HERE. But in short, I’ve always enjoyed STEM focused classes the most so I figured I would end up in some related field as an adult. The pharmacy specific spark first occurred through my own illness/medication side effects experience during high school and this experience is still something I carry with me everyday as a pharmacist as I now care for patients.

Hospitals 52

Hospitals Patient Care 52

pharmaphorum

APRIL 27, 2022

As the landscape of healthcare changes, so too must the way that we interpret and measure performance and success. This is particularly evident in marketing. Before the COVID-19 pandemic, measuring engagement typically involved detailed follow-ups, contacting a pool of practitioners to gauge their awareness of a particular product and then extrapolating that information across the country.

Hospitals 116

Hospitals Communication 116

Roots Analysis

APRIL 26, 2022

Women’s digital health involves the initiatives taken by industry stakeholders and researchers, which include technological remedies, such as mobile apps, software, wearable devices and diagnostic tools that exclusively aid in improving female health and wellness. Since it is primarily focused on women’s healthcare, it is termed as Female Technology or FemTech.

52

52

Outsourcing Pharma

APRIL 28, 2022

The addition of the facility in Pennsylvania will help meet the increasing demand for temperature-controlled clinical packaging, storage, and distribution.

Packaging 52

Packaging 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Mirror

APRIL 24, 2022

Paris, will open in May (18-19) with connectivity, sustainability and user experience identified as the key trends in 2022 influencing innovation across pharmaceutical packaging and drug delivery. The event – which unites major players in pharmaceutical packaging, drug delivery, medical devices and machinery – returns to the Paris Expo, Porte de Versailles (Hall 7.2) and will see 5000 attendees and some 300+ companies exploring next generation technologies and looking ahead to debate the major i

Packaging 52

Packaging 52

pharmaphorum

APRIL 26, 2022

Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there is untapped potential in the area. Ben Hargreaves speaks to companies that are developing therapies not just in gastrointestinal conditions but also in broader areas, such an immuno-oncology. The interest in how the human microbiome influences health has grown substantially in the last decade.

Immunization 115

Immunization FDA 115

Fuld

APRIL 24, 2022

Robert H. Goddard, the father of modern rocket propulsion said, “It is difficult to say what is impossible, for the dream of yesterday is the hope of today and the reality of tomorrow.” Thanks to FinTech, from peer-to-peer lending to being rewarded for making our bill payments on time, the dream of a global cashless economy is more realistic than ever.

Grocery Stores 52

Grocery Stores Insurance 52

Outsourcing Pharma

APRIL 26, 2022

The decentralized clinical trial specialist has acquired CureClick to add to its offerings a platform intended to expand awareness of study participation.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Mirror

APRIL 24, 2022

OSAKA, Japan and TOKYO, Japan. Shionogi & Co., Ltd. and NEC Corporation, today announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. NEC OncoImmunity, an NEC subsidiary that specializes in artificial intelligence-driven biotechnology, is also participating in this research collaboration.

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 29, 2022

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and heart failure therapy Farxiga. The new site will be at Kendall Square and will serve as the new corporate headquarters for Alexion – which is currently based across the Charles River in Boston’s Seaport District – as well as housing around 1,500 R&D staff from AZ and Alexion in a new purpo

Vaccines 111

Vaccines 111

Pharma Times

APRIL 28, 2022

Long-acting hypertension treatment could provide patients with an injection of medication every six months

50

50

Outsourcing Pharma

APRIL 26, 2022

The US agency has expanded its approval of Veklury to include use in pediatric patients 28 days and older who have tested positive for the COVID-19 virus.

FDA 52

FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Mirror

APRIL 24, 2022

Barcelona, Spain, April 20, 2022 – Inke, a leading global manufacturer of inhalation APIs wholly owned by Neuraxpharm Group, announces it is investing €9 million to increase production capacity for inhalation APIs. The investment will allow Inke to triple the production capacity of chemical synthesis and the micronisation of inhalation APIs at its manufacturing plant in Castellbisbal, Barcelona, by 2024.

52

52

pharmaphorum

APRIL 28, 2022

Orders for Merck & Co’s oral antiviral for COVID-19 helped to swell the drugmaker’s first quarter revenues by a massive 50%, although underlying growth was also strong. Lagevrio (molnupiravir) added $3.2 billion to Merck’s top line of $15.9 billion, but even without the drug sales would have risen 19% thanks to a strong performance from cancer immunotherapy Keytruda (pembrolizumab) and the Gardasil human papillomavirus (HPV) vaccine range.

Vaccines 105

Vaccines FDA 105

Pharma Times

APRIL 29, 2022

InRange is the first worldwide multicentre RCT to compare second generation basal insulins

49

49

Outsourcing Pharma

APRIL 25, 2022

The 2022 edition of the Highly Potent Active Pharmaceutical Ingredients Summit (June 28 to 30 in Boston) will take on a range of topics, including safety.

52

52

Pharma Mirror

APRIL 24, 2022

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12. NorthX has recently established an innovation hub to offer support to partners in achieving their long-term drug development goals.

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 25, 2022

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . BehaVR and Sumitomo signed a potential $140 million deal to create virtual reality (VR) therapies to treat social anxiety disorder, generalised anxiety disorder, and major depressive disorder.

FDA 105

FDA 105

Pharma Times

APRIL 26, 2022

The Foundation also launched a new collaboration with Diabetes UK and the Juvenile Diabetes Research Foundation UK

49

49

Med Ed 101

APRIL 27, 2022

KE is an 87-year-old female with a history of CKD. The most recent GFR was 21 mls/min which has remained stable from the most previous lab checks. Other diagnoses include atrial fibrillation, hypertension, GERD, back pain, muscle spasms, neuropathy, pruritus, and anxiety. She presents with her daughter today and she reports that she is most […].

45

45

pharmaphorum

APRIL 25, 2022

CAR-T therapies have revolutionised the treatment of some blood cancers, but are costly as well as time- and resource-intensive. Now, US researchers think one solution could be an implant that generates T cells within the body to attack the cancer. It is early days for the concept, but its developers – from North Carolina State University and the University of North Carolina – have completed a proof-of-concept study that shows it works in animal models and could start to attack the cancer in a s

Hospitals 105

Hospitals FDA 105

pharmaphorum

APRIL 28, 2022

OMass Therapeutics has raised an impressive $100 million in a Series B financing that is said to be the largest ever for a UK biotech focusing on small-molecule drug development. The Oxford-based company said the financing, led by venture capital arms of Google and Sanofi as well as Northpond Ventures, will be used to bring its portfolio of drug candidates for immunological and rare disease into clinical trials.

105

105

pharmaphorum

APRIL 29, 2022

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. The Danish drugmaker has reported the first phase 3 results with its new basal insulin product – insulin icodec – which backs up earlier data suggesting it could provide effective blood glucose control when injected just once a week.

98

98

pharmaphorum

APRIL 29, 2022

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post focuses on how poor managers frequently treat employees; it might hold some hints to support and retain strong talent – and benefit from their continued enthusiasm and drive for results.

Communication 98

Communication 98

pharmaphorum

APRIL 28, 2022

Pfizer’s $1.2 billion licensing deal with Biohaven for rights to oral migraine drug rimegepant is approaching a payoff after the European Commission approved the drug. The regulator cleared the oral CGRP inhibitor as Vydura for both treatment and prevention of episodic migraine attacks, becoming the first drug to be authorised for both uses in the EU, with a review also underway by the UK authorities.

FDA 98

FDA 98

pharmaphorum

APRIL 26, 2022

Biofourmis has raised $300 million in fourth-round financing, sending its value rocketing to around $1.3 billion and injecting some fresh momentum into the digital health sector after a slowdown in fundraising in the first quarter. The Boston-based startup – which has a business model straddling digital therapeutics (DTx), artificial intelligence-powered patient management and provision of virtual care – said the Series D will be used to fund clinical trials of its DTx candidates, scale up its v

Hospitals 98

Hospitals FDA 98

pharmaphorum

APRIL 28, 2022

Vifor Pharma and Cara Therapeutics’ Kapruvia has become the first drug to be approved in the EU to treat one of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease (CKD) – chronic itching. The European Commission has cleared Kapruvia (difelikefalin) as an injectable treatment for chronic itching, also known as pruritus, in adult CKD patients on dialysis.

98

98